Private Equity

Alliance Cancer Specialists and IDEOlogy Health unite to bring the latest cancer research directly to community care teams, enhancing patient outcomes.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

The Sterling Group's acquisition of The Scruggs Companies signals a major private equity push into America's vital and aging water infrastructure sector.

The sale of Parkdale Center highlights private equity's growing appetite for specialized mental healthcare and marks a strategic entry into Indiana's strained market.

Anthem Blue Cross Foundation's new impact investing program is funding housing, jobs, and wellness, signaling a major shift in healthcare strategy.

A new partnership makes Petco Park a leader in sustainability, diverting over 2,000 tons of waste from landfills through a revolutionary composting system.

Following a major investment from Gryphon Investors, HRSoft is stacking its board with tech veterans to accelerate growth, product innovation, and M&A.

A financially struggling healthcare firm makes a bold leap into neurotechnology, but can it compete with giants like Neuralink in the high-risk BCI race?

Forget crowded city hotels. This glamping company is turning its nature retreats into soccer hubs for the 2026 World Cup, blending sport and scenery.

The Panama-born coffee roaster expands its La Cosecha spot with an all-day menu, bar, and free creative studio, signaling a shift in urban hospitality.

Once a promising EV startup, Bollinger Motors has collapsed. Its complete manufacturing assets and new trucks are now up for auction in a cautionary tale.

Industry veterans unite to acquire GreenFruit Avocados, creating a vertically integrated giant to challenge market leaders with a grower-focused model.

Swiss medtech vVARDIS secures a major Apollo investment, valuing it over $1B for its revolutionary non-invasive cavity treatment, Curodont™.

VSCP's appointment of Kurt Hilzinger signals a strategic push to leverage deep operational expertise in the competitive healthcare private equity market.

A major trial shows once-weekly rezafungin is as effective as daily drugs for preventing deadly fungal infections, heralding a new era for patient care.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

As private equity shifts from financial engineering to operational value, firms are doubling down on supply chain expertise to unlock hidden gains and mitigate risk.

Pelican Energy Partners' strategic acquisition of EAI and its proprietary decontamination tech signals a major PE push into the growing nuclear cleanup market.

A new report reveals record M&A optimism for Europe's digital infrastructure, but a widening valuation gap and resource scarcity create a complex landscape.

Cementos Pacasmayo reports record Q1 profits just as Swiss giant Holcim finalizes its controlling acquisition, signaling a new era for Peru's cement market.